
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-10-31 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-10-15 | Marjorie Taylor Greene | house | Purchase | $1,001 - $15,000 |
| 2025-09-11 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
No financial data available for NVO.
Company may not file with SEC or CIK is unresolved.
Fast Money Panel Says Novo Nordisk Now More Compelling Than Eli Lilly After Falling 70%
Novo Nordisk Broadens GLP 1 Story With Pediatric And Rare Disease Gains
US prescription spending could top $1 trillion. GLP-1s lead the way
GLP-1 Sales Continue to Lift Eli Lilly. Does That Make LLY Stock a Buy?